Biotech’s top investors, ranked

Hello,

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

• We ranked the top biotech investors of 2021 who are poised to dominate next year too;
• Included Health is gearing up for an IPO early next year;
• Meet Virtue, a new investor fund for digital health.

If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let's get to it…

---

Here are the 18 investors set to shape biotech in 2022

• Insider analyzed more than 90 IPOs to find the top venture-capital firms that led biotech in 2021.
• Arch, Novo Holdings, and Flagship Pioneering topped the list with more than $1 billion in equity.
• Several firms have already raised new funds and laid out investment plans for next year.

Check it out>>

---

Exclusive: Grand Rounds, now Included Health, is gearing up for an IPO in early 2022

• Included Health has hired firms to gear up for an IPO, four people told Insider.
• In 2021, the health startups Grand Rounds Health and Doctor on Demand merged to form Included.
• The company offers services such as mental-health care and specialty referrals.

See the scoop now>> 

---

Health systems and insurance companies are investing in first-time funds like the newly minted firm Virtue to capitalize on the digital health boom

• The investor Sean Doolan is launching Virtue, his first solo fund, with $31.25 million in funding.
• Doolan previously invested in healthcare companies in his role at Global Founders Capital.
• He told Insider the booming industry needed smaller and faster investors.

Dive in>>

---

More stories we're reading:

• SoftBank just invested $300 million in the mental-health startup Cerebral. The lead investor told us about how he plans to steer the mega-VC toward more digital-health deals. (Insider)
• An inside look at Biogen's leadership disaster in the wake of the Aduhelm approval (STAT)
• Scientists found a 2nd type of Omicron that's harder to track since tests struggle to distinguish it from other variants (Insider)
• How the COVID-19 virus could mutate next (Nature)
• A top CVS Health exec breaks down the 4 ways the company is using technology to transform how patients get care and prescriptions (Insider)

---

-Leah